ABSTRACT Twenty patients with bronchial asthma who also had gastro-oesophageal reflux were investigated. The severity of their reflux was graded using symptom score of heartburn and regurgitation and by the following investigations: barium swallow and meal, fibreoptic endoscopy and biopsy, manometry and pH monitoring of the distal oesophagus, and an acid infusion test. Full lung function studies were performed and patients were entered into a double-blind crossover study using cimetidine to control their reflux in order to assess beneficial effects with respect to their respiratory problems. Eighteen patients completed the study. Significant improvements were seen in reflux and night time asthmatic symptoms, both these indices being measured on a scoring system. Home monitoring of peak flow values showed a statistical improvement for the last peak flow reading of the day. Fourteen patients felt that their chest symptoms had significantly improved during the cimetidine period.
Gastro-oesophageal reflux commonly produces symptoms in subjects of all ages. The dominant complaints are usually related to the upper gastrointestinal tract and include heartburn, regurgitation, and occasionally dysphagia. Patients with re'lux are also liable to respiratory complications leading to severe, progressive, and disabling pulmonary damage.' More recently attention has been drawn to an association between reflux and exacerbations of bronchial asthma, 23 and there have been several studies suggesting subjective improvement in such patients after surgical correction of hiatus hernia. [3] [4] [5] In this study we have attempted to demonstrate a measurable improvement in symptoms and respiratory function in a group of asthmatic patients, who also had well-documented reflux, by controlling their reflux with cimetidine in a double-blind, crossover trial.
Methods
Informed consent for study was obtained from 20 patients, 13 men and seven women, whose ages ranged from 30-65 years (mean 54 years). All patients had bronchial asthma and were attending the Department of Thoracic Medicine outpatient clinic. All but one had symptomatic reflux.
The diagnosis of asthma was made mainly on clinical grounds (table 1). All patients had nocturnal wheezing and 13 had either a personal or family history of atopic disease. Nineteen patients showed a good response to the administration of disodium cromoglycate or corticosteroid drugs, but one patient was managed satisfactorily with bronchodilator therapy alone. Eleven patients had reversible airways obstruction, as demonstrated by an improvement of 20% or more in the forced expiratory volume in the first second after the inhalation of a broncho- 
Results
Of the 20 patients entered into the study, 18 completed both trial periods. One patient, while on active tablets, had an acute exacerbation of her asthma and required prolonged inpatient treatment. The other patient failed to attend after the first six weeks, having taken placebo tablets.
In the remaining 18 patients, 11 received placebo tablets for the first six weeks and seven received cimetidine.
The initial analysis of the data demonstrated that there was no significant carry-over effect with any of the measured indices and thus it was possible to test for treatment effect in every case by comparison of the results obtained at the end of each treatment period.
After cimetidine the reflux symptom score improved in 14 patients compared with the score after placebo, but in the other four patients was slightly worse. However the median values for the reflux symptom scores showed a significant improvement (p<0 02).
At the completion of the trial patients were asked which treatment period they had preferred with respect to their chest symptoms. In 14 this was the cimetidine period, in three the placebo period, and one had no preference.
There was objective evidence of improvement during the cimetidine period in that the median night time asthmatic scores fell significantly (p<0-05). During the day however, although the median scores for asthma during the final three weeks for each period also fell with cimetidine, this improvement was not significant.
The peak flow values shown (table 3) are the median and range of patients' average values at each of the four readings over the final three weeks of -the placebo and cimetidine periods. Ailthough there was a trend for these peak flow readings to improve during cimetidine treatment, the difference between the two treatment periods was statistically significant only for the last reading of the day (p<0-05). The majority of the peak flow improvements were minor and probably of little clinical significance. There was no difference in the frequency of use of inhaled bronchodilator or other therapy during each of the treatment periods. The full pulmonary function tests showed no significant change at the end of each treatment period. A possible relationship between bronchial asthma and reflux is less well defined. However, a high frequency of hiatus hernia with or without reflux in aduilts with bronchial asthma has been noted.4 18 The first point worthy of emphasis from our study is the ease with which 19 asthmatic patients with symptomatic reflux were found on routine questioning in a short period of time. On reviewing the histories, nine of these patients developed reflux symptoms before the onset of bronchial asthma. Ten patients were aware that an asthmatic episode was frequently preceded by severe reflux symptoms, eight patients noted no such relationship, and one thought that reflux symptoms developed as a result of the asthmatic attack.
The present study differs from previous reports in two important respects. Firstly, cimetidine has been used instead of antireflux surgery as a treatment because it is a potent inhibitor of gastric acid secretion reducing markedly both the volume and hydrogen ion concentration of gastric juice.9 20 This study has shown that cimetidine was effective in relieving the symptoms of reflux in most of the patients. Furthermore, an improvement in asthmatic symptoms appears to have been associated with cimetidine therapy, particularly at night, a feature which might be expected if nocturnal reflux precipitates or aggravates respiratory symptoms. Tihree patients experienced such marked improvement in their respiratory symptoms while taking cimetidine that they have received a more prolonged course of this therapy with apparent benefit.
Secondly, an attempt has been made to demonstrate objective improvement with respect to respiratory function whereas previous work has only reported subjective benefit. Although quite comprehensive pulmonary function tests were performed, only the daily peak flow readings show a trend towards improvement. One of these reached statistical significance but it was disappointing that the magnitude of the improvement was so small. However, the subjective improvement experienced by most of the patients should not be ignored.
Gastro-oesophageal reflux as a trigger in bronchial asthma has been suggested in 25 out of 28 patients whose asthma was improved or completely relieved by surgical repair of hiatus hernia, ailthough no objective evidence of the diagnosis of asthma or of subsequent improvement was given.2 Klotz and Moeller5 quoted five further patients whose asthma was alleviated by surgical or medical control of reflux. Mays'8 in addition confirmed improvement in respiratory symptoms in patients with well-documented asthma by controlling reflux medically. It is interesting to speculate as to the possible mechanisms involved. If reflux can trigger bronchial asthma, is the mechanism simply one of intrapulmonary aspiration of refluxed gastric contents as suggested by Babb et al?3 If so this is more likely to occur with the patient recumbent and therefore to give rise to nocturnal problems. Such a theory is attractive in that asthmatic patients with enhanced bronchomotor response to various irritant and pharmacological stimuli would be more likely to respond to even minute volumes of acid gastric contents within their lungs and subsequent stimulation of irritant receptors. 21 However, evidence that microaspiration does take place in asthmatic patients is lacking,22 apart from one case of a child during a barium study.23 In our own experience two patients with severe asthma and reflux studied by the method of Reich et al,'6 but with continuous external gamma counting throughout the night, failed to show any evidence of aspiration into the lungs des-pite frequent episodes of marked reflux.
A more attractive theory relating reflux and asthma has been put forward by Mansfield and Stein.24 Fifteen patients with established bronchial asthma and demonstrable reflux were studied before, during, and after infusion of 01 N hydrochloric acid into the oesophagus. There was undoubted subjective and objective evidence of bronchoconstriction associated with this acid infusion which improved after relief of symptoms with antacids. These authors postulate a vagal reflex, mediated by oesophageal receptors, which is responsible for the association between reflux and asthma.
It is unlikely that cimetidine has any direct effect upon bronchial smooth muscle by virtue of H2 receptor antagonism. Although it is thought that H2 receptors do exist in the human lung their role in the control of bronchoconstriction is far from clear. There is little doubt that histamine Hi receptors within the lung subserve broncho-constriction and the benefits of HI antagonists have been well documented. 25 26 No study so far has shown any significant bronchodilator effect which could be attributed to cimetidine in either healthy or asthmatic subjects after histamine challenge.27 28 It is more likely, therefore, that any effects attributable to cimetidine in the present study are related to its action in reducing the volume and acidity of refluxed material into the body of the oesophagus. This would reduce the likelihood of associated bronchial asthma, whether the mechanism is one of pulmonary aspiration of oesophageal contents or a vagally mediated reflex.
Although asthma and reflux may be associated this does not imply that the reflux is necessarily the primary abnormality. Clemencon and Osterman29 suggested that intrathoracic and intraabdominal pressure changes such as occur in acute asthma may induce reflux. Pellegrini et a130 have shown that an asthmatic attack or a bout of coughing may precede episodes of reflux. Thus a potential self-propagating situation can be envisaged where reflux, either by aspiration or a reflex mechanism, can aggravate asthma which itself can induce further reflux.
What, therefore, can we conclude about a relationship between reflux and asthma? There seems little doubt that controlling reflux may play a part in the management of asthma and that control of asthma may help reflux. We would suggest that at least in some patients nocturnal exacerbations of asthma could be related to acid entering the lower oesophagus. Certainly in patients in whom bronchial asthma is difficult to control, reflux should be considered and in a proportion of these patients medical or surgical correction of this reflux may have beneficial results with respect to their pulmonary problem. 
